Cannabis stocks remained remarkably range-bound and are now up 0.1% in February. 36% of the 56 stocks tracked here rose in price, with 2 double-digit percentage gainers and 5 double-digit percentage losers. The percentage of stocks with volume above the 30-day average was 23%, down from 25% in the prior session, with four stocks trading over $5mm in value. Four of the ten highest dollar-volume stocks rose in price as thirteen traded above $1mm. The 420 Investor Cannabis Stock Index decreased from 80.92 to 80.88, reflecting a change of +9.2% after a 88.8% gain in 2016. The index began 2013 at 100, 2014 at 159.1, 2015 at 130.7, 2016 at 39.25 and 2017 at 74.10.
This table, which has a goal of including the most actively traded names (with a minimum price of $0.001), includes dual-listed tickers ACBFF, APHQF, BLOZF, EMMBF, GRPOF, MGWFF, MRPHF, OGRMF, SPLIF, SPRWF, THCBF and TWMJF, and thus is not reflective of all the trading activity in those tickers.
Stocks moving more than 5% on more than $500k in volume included Acology (ACOL) to the upside and Mountain High Acquisition Corp (MYHI), Novus Acquisition & Development Corp (NDEV), Pharmacyte Biotech (PMCB), Vitality Biopharma (VBIO), OWC Pharma (OWCP), OrganiGram (OGRMF) and mCig (MCIG) to the downside.
The Daily Dab is brought to you by 420 Investor, a large community of investors seeking to capitalize on cannabis. For just a little over a dollar a day on an annual subscription ($420, or $42 per month), you can get all of the benefits of being a part of 420 Investor, including analysis, alerts, trade recommendations, chat, forums and video updates. Want a quick way to stay on top of the sector? The monthly 420 Investor Newsletter will keep you informed for just $149 per year. Find out why 420 Investors are addicted to the service. To learn more about the sector, download your free guide.
Check us out on Facebook too!